This information is intended for
US healthcare professionals
When fats are not broken down (digested), this can result in getting fewer calories or not enough calories, not being able to gain or maintain weight, losing weight, having lower levels of some vitamins, and not getting enough of certain kinds of fats (such as omega-3 fats) which are important for normal growth and development.
Your doctor may prescribe RELiZORB for you if your body needs help breaking down (digesting) fats from your enteral tube feeding formula. RELiZORB is designed for use by people who have trouble breaking down (digesting) fats and need enteral tube feeding. People who many benefit from RELiZORB cannot properly make digestive enzymes. If fats are not broken down, you can have stomach pain, gas, oily or foul-smelling stools, an unusually full feeling, or feel like throwing up.
Greater than 90% of available fats hydrolyzed in most enteral formulas tested, including Nutren 2.0, Impact Peptide 1.5, Peptamen 1.5, Peptamen AF, and Nutren 1.0. Percentage of fat hydrolysis is estimated based on label claim for content, calculated using 500 mL of formula with a pump rate of 120 mL/hr. Formula manufacturers may change the composition of their formulas, which may affect the operation of RELiZORB. Please refer to formula product websites for recent product descriptions, ingredients, and nutritional information.
RELiZORB is a digestive enzyme cartridge that contains the enzyme lipase. RELiZORB is used with enteral tube feeding to help break down the fats. Lipases are enzymes that are normally made in the body to break down (digest) fats (trigyclerides) into an absorbable form (fatty acids and monoglycerides). The lipase enzyme used in RELiZORB is attached to the white beads (iLipase), which are visible through the side of the cartridge.
This information is intended for
US healthcare professionals
You are now leaving the RELiZORB
product website to view the
Alcresta Therapeutics corporate website.